Stock's Roundup of the Biotech Industry - HEB, DNDN, GERN, CELG

Pompano Beach, FL -- (SBWIRE) -- 12/11/2012 -- No Limit Stocks - NOLIMITSTOCKS.com covers all the latest on up and coming stocks in the market. No limit Stocks team contain experts that study and analyzes the stock market and help individuals break through the limits and make them better & more successful investors.

Hemispherx BioPharma, Inc (NYSEAMEX:HEB) percentage change dropped -14.84% to close at $0.620 with the total traded volume of 8,501,900 shares more than average volume of 2.17 million shares.

Company's lowest price during last trade was $0.60 while its highest price remained $0.73 for the day. HEB's total market capitalization is $93.63 million along with 151.01 million shares outstanding. Its beta value stands at 1.29 points and its earning per shares remained $-0.11.

Can HEB can Show a Strong Recovery? Find out in This Research Report

Dendreon Corporation (NASDAQ:DNDN) reported an upsurge of +3.49% after opening at the price of $5.00 its closing price for the day was $5.04.

DNDN's total trading volume for the day was 8,321,100 shares versus its average volume of 4.46 million shares. Company's current market capitalization stands at $777.76 million along with 154.32 million shares.

Dendreon Company's earning per share is $-2.13 while its beta value stands at 3.87 times.

If we look at previous 5 day's performance of the stock, it remained optimistic with the gain of 13.26%, in its last one month's trade it gained 24.75%.

Where DNDN is Aheaded Exactly? Find Out Here

Geron Corporation (NASDAQ:GERN) percentage change climbed +15.09% to close at $1.22 with the total traded volume of 6,052,200 shares more than average volume of 860,906.00.

Its market capitalization is $159.52 million and EPS was $-0.67. Its beta value stands at 1.02 times. GERN's shares were trading within the range of $1.17-$1.43 while its opening price was $1.18.

If we look at previous three months trade, it plunged more than -4% while in last 5 day's it remained down -17.57%.

How Should Investors Trade GERN Now? Find Out Here

Celgene Corporation (NASDAQ:CELG) opened at the price of $78.77 whereas its previous closing price was recorded at $80.50. CELG gained 2.31% and traded within the day range of $78.68 - $80.99 for the day, 52week range of the stock remained in between $58.53 - $81.24. Total volume of the stock was 4,884,800 shares during last trade while its average volume is 2.75 million shares.

Company's total market capitalization stands at $34.05 billion along with 422.99 million outstanding shares.

Where CELG is Aheaded Next? Find Out Here

About No Limit Stocks
NOLIMITSTOCKS.com is made up of a team of professional analyst that possess over 30 years of expert, stock market experience. Our goal is to research thousands of companies and provide investors with the latest insights in the market with stocks that can make explosive profits. We study the hottest companies so you don't have to!

Our newsletter is always free to Join and offers a variety of useful investors tools that will help you break the limits! There will be no regrets!